New hope for ALS patients: experimental drug made available through expanded access
NCT ID NCT06408727
First seen Apr 10, 2026 · Last updated May 24, 2026 · Updated 9 times
Summary
This program offers early access to an experimental drug called CNM-Au8 for people with amyotrophic lateral sclerosis (ALS), a serious nerve disease. Participants must be 18 or older and have a confirmed ALS diagnosis. The goal is to provide treatment while more research is done, but this is not a cure and ongoing management is still needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Columbia Unniversity
New York, New York, 10032, United States
-
Duke University
Durham, North Carolina, 27704, United States
-
Northwestern University
Chicago, Illinois, 60611, United States
-
Nova Southeastern University
Fort Lauderdale, Florida, 33328, United States
-
Pennsylvania State University
Hershey, Pennsylvania, 17033, United States
-
Synapticure
Chicago, Illinois, 60613, United States
-
Texas Neurology
Dallas, Texas, 75206, United States
-
University of Iowa
Iowa City, Iowa, 52242, United States
Conditions
Explore the condition pages connected to this study.